Thrombocytopenia in pregnancy: Diagnosis, pathogenesis and management

Blood Reviews

Volumn 10, Issue 1, 1996, Pages 8-16

  Crowther, M A ^b   Burrows, R F ^b   Ginsberg, J ^b   Kelton, J G ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CORTICOSTEROID; HEPARIN; IMMUNOGLOBULIN; PHOSPHOLIPID ANTIBODY; PREDNISONE; QUINIDINE; QUININE; THROMBOCYTE ANTIBODY; ZIDOVUDINE;

ALLOIMMUNIZATION; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; AVASCULAR NECROSIS; BLEEDING; CATARACT; CESAREAN SECTION; CLINICAL FEATURE; CLINICAL TRIAL; DIABETES MELLITUS; FEMALE; FETUS WASTAGE; FOLIC ACID DEFICIENCY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTRAVENOUS DRUG ADMINISTRATION; LABORATORY TEST; LIVER FATTY DEGENERATION; MATERNAL HYPERTENSION; META ANALYSIS; NEWBORN DISEASE; OSTEOPOROSIS; PATHOGENESIS; PATIENT CARE; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0029964181     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(96)90015-6     Document Type: Article

References (83)

1. Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Eng J Med 1993; 329: 1463-1466.
2. McCrae KR, Samuels P Schreiber AD. Pregnancy associated thrombocytopenia: pathogenesis and management. Blood 1992; 11: 2697-2714.
3. Matthews JH, Benjamin S, Gill DS, Smith NA. Pregnancy associated thrombocytopenia: Definition, incidence and natural history. Acta haematol 1990; 84: 24-29.
4. Anteby E, Shalev O. Clinical relevance of gestational thrombocytopenia of < 100000/microlitres. AJH 1994; 47: 118-122.
5. Burrows RF, Hunter DJS, Andrew M, Kelton JG. Prospective study investigating the mechanism of thrombocytopenia in pre-eclampsia. Obstet Gynecol 1987; 70: 334-338.
6. Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142: 159-167.
7. Van Dam PA, Reneir M, Baekelandt M, Buyaert P, Uyttenbroeck F. Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes and low platelets in severe pre-eclampsia. Obstet Gynecol 1989; 73: 97-102.
8. Pritchard JA, Cunningham FG, Pritchard SA, Mason RA. How often does maternal preeclampsia-eclampsia incite thrombocytopenia in the fetus. Obstet Gynecol 1987; 69: 292-295.
9. Burrows RF, Andrew M. Neonatal thrombocytopenia in the hypertensive disorders of pregnancy. Obstet Gynecol 1990: 76: 234-238.
10. Katz VL, Thorp JM, Rozas L, Bowes WA. The natural history of thrombocytopenia associated with pre-eclampsia. Am J Obstct Gynecol 1990; 163: 1142-1143.
11. Al-Mofda SM, Osman ME, Kides E, al-Momen AK, al-Herbish AS, al-Mobaireek K. Risks of thrombocytopenia in the infants of mothers with idiopathic thrombocytopenia. Am J Perinatology 1994; 11: 423-426.
12. Kernoff LM, Malan E, Gunston K. Neonatal thrombocytopenia complicating autoimmune thrombocytopenia in pregnancy. Ann Int Med 1979; 90: 55-56.
13. Burrows RF, Kelton JG. Pregnancy in patients with idiopathic thrombocytopenic purpura: assessing the risk for the infant at delivery. Obstet Gynecol Surv 1993; 48: 781-788.
14. Druzin ML, Stier ES. Maternal platelet count at delivery in patients with idiopathic thrombocytopenic purpura, not related to perioperative complications. J Am Coll Surg 1994; 179: 264-266.
15. He R, Reid DM, Jones CE, Shulman NR. Spectrum of lg classes, specificities, and titres of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura. Blood 1994; 83: 1024-1032.
16. Kelton JG. The serological investigation of patients with autoimmune thrombocytopenia. Thromb Hemostasis 1995; 74: 228-233.
17. Hohlfeld P, Forestier F, Kaplan C, Tissot J-D, Daffos F. Fetal thrombocytopenia: a retrospective survey of 5194 fetal blood samples. Blood 1994; 84: 1851-1856.
18. Cook RL, Miller RC, Katz VL, Cefalo RC. Immune thrombocytopenic purpura in pregnancy: a reappraisal of management. Obstet Gynecol 1991; 78: 578-583.
19. Mandelbrot L, Schlienger I, Bongain A, Berrebi A, Pons JC, Ciraru-Vigneron N, Gillet JY, Delfraissy JF. Thrombocytopenia in pregnant women infected with human immunodeficiency virus: maternal and neonatal outcome. Am J Obstet Gynecol 1994; 171: 252-257.
20. Rogers MF, Jaffe HW. Reducing the risk of maternal-infant transmission of HIV: a door is opened. [editorial]. N Eng J Med 1994; 331: 1222-1223.
21. Ballem PJ, Belzberg A, Devine DV et al. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N Eng J Med 1992; 327: 1779-1784.
22. Connor EM, Sperling RS, Gelber R et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Eng J Med 1994; 331: 1173-1180.
23. Kuhn L, Stein ZA. Mother-to-infant HIV transmission: timing, risk factors and prevention. Paediatric Perinatal Epidemiology 1995; 9: 1-29.
24. Peckham C, Gibb D. Mother-to-child transmission of the Human Immunodeficiency virus. N Eng J Med 1995; 333: 298-302.
25. Weiner CP. Thrombotic microangiopathy in pregnancy and the postpartum period. Semin Hematol 1987; 24: 119-129.
26. Rock GA, Shumack KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA and the Canadian Apheresis Study Group. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. NEJM 1991; 325: 393-297.
27. Anonymous. Chapter 51: Gastrointestinal Disorders. In: Cunningham Williams Obstetrics, 19th edn. FG, MacDonald PC, Leveno KJ, Gant NF, Gilstrap LC, eds. Nonwalk, CT: Simon and Schuster, 1993; 1154-1156.
28. Abramowicz JS, Shere DM, Woods JR. Acute transient thrombocytopenia associated with cocaine use in pregnancy. Obstet Gynecol 1991; 78: 499.
29. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M. Kelton JG. Heparin-induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractionated heparin. N Eng J Med 1995; 332: 1330-1335.
30. Warkentin TE, Kelton JG. Heparin induced thrombocytopenia. Prog Thromb Hemostasis 1991; 10: 1-34.
31. Chong BH. Heparin induced thrombocytopenia. Aust NZ J Med 1992; 22: 145-152.
32. Magnani HN. Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172). Thromb Hemostasis 1993; 70: 554-561.
33. Arnout J, Spitz B, VanAssche A, Vermylen J. The antiphospholipid syndrome and pregnancy. Hypertension in Pregnancy 1995; 14: 147-178.
34. Triplett DA. Protean clinical presentation of antiphospholipid-protein antibodies (APA). Thrombosis Haemostasis 1995; 74: 329-337.
35. Galli M, Comfurius P, Maasen C et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to plasma protein cofactor. Lancet 1990; 335 (8705); 1544-1547.
36. 2-Glycoprotein I. (Apolipoprotein H) Proc Natl Acad Sci USA 1990; 87: 4120.
37. Escalante A, Brey RL, Mitchell BD, Dreiner U. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus. Am J Med 1995; 98: 559-565.
38. Conley CL, Hartmann RC. A hemorrhagic disorder caused by circulating anticoagulants in patients with disseminated lupus erythematosus. J Lab Clin Invest 1952; 31: 621-622.
39. Lockwood CJ, Rand JH. The immunobiology and obstetrical consequences of antiphospholipid antibodies. Obstet Gynecol Survey 1994; 49: 432-441.
40. Feinstein DI. Immune Coagulation Disorders. In: Colman RW, Hirsh J, Marder VJ, Salzman EW. eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia, PA: JB Lippincott, 1994: 891-896.
41. Ginsberg JS, Brill-Edwards P, Johnston M et al. Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: A cross-sectional study. Blood 1992; 80: 975-980.
42. Triplett DA, Brandt JT, Kaczor D, Schaeffer J. Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. Am J Clin Path 1983; 79: 678-682.
43. Feinstein DI. Lupus anticoagulant, anticardiolipin antibodies, fetal loss, and systemic lupus erythematosus. Blood 1992; 80: 859-862.
44. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Int Med 1990; 112: 682-698.
45. Asherson RA. A 'primary' antiphospholipid syndrome? J Rheum 1988; 15: 1742-1746.
46. Shapiro GA. Antiphospholipid syndrome in obstetrics and gynecology. Sem Thromb Hemostasis 1994; 20: 64-70.
47. Harris EN, Chan Jk, Asherson RA, Aber VR, Gharavi AE, Hughes GR. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Int Med 1986; 146: 2153-2156.
48. MacLean MA, Cumming GP, McCall F, Walker ID, Walker JJ. The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages. Br J Obstet Gyneco 1994; 101: 103-106.
49. Parke AL, Wilson D, Maier D. The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies and women who have never been pregnant. Arthritis Rheum 1991; 34: 1231-1235.
50. Silver RK, MacGregor SN, Pasternak JF, Neely SE. Fetal stroke associated with elevated maternal anticardiolipin antibodies. Obstet Gynecol 1992; 80: 497-499.
51. Scott JR, Rote NS, Branch DW. Immunologic aspects of recurrent abortion and fetal death. Obstet Gynecol 1987; 70: 645-656.
52. Silver RM, Draper ML, Scott JR, Lyon JL, Reading J, Branch DW. Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obstet Gynecol 1994; 83: 372-377.
53. Harris EN, Spinatto J. Anticardiolipin screening of healthy pregnant women is not a useful predictor of pregnancy outcome. Clin Exp Rheum 1990; 8: 220.
54. Silveira LH, Espinoza LR. Course of aPL in Patients with primary antiphospholipid syndrome before, during and after pregnancy treated with low dose aspirin. (Letter). J Rheum 1993; 20: 1440-1441.
55. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992; 80: 614-620.
56. Kwak JYH, Barini R, Gilman-Sachs A, Beaman KD, Beer AE. Down regulation of maternal antiphospholipid antibodies during early pregnancy and pregnancy outcomes. Am J Obstet Gynecol 1994; 171: 239-246.
57. Harris EN. Maternal autoantibodies and pregnancy. I. The antiphospholipid antibody syndrome. Bailliere's Clin Hematology 1990; 4: 53-68.
58. Lockshin MD, Druzin ML, Goei S Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. NEJM 1985; 313: 152-156.
59. Stafford-Brady FJ, Gladman DD, Urowitz MB. Successful pregnancy in systemic lupus erythematosus with an untreated lupus anticoagulant. Arch Int Med 1988; 148: 1647-1648.
60. Kampe CE. Clinical syndromes associated with lupus anticoagulants. Sem Thromb Hemostasis 1994; 20: 16-20.
61. Trudinger BJ, Stewart GJ, Cook CM, Connelly A, Exner T. Monitoring lupus anticoagulant-positive pregnancies with umbilical artery flow velocity waveforms. Obstet Gynecol 1988; 72: 215-218.
62. Silver RK, MacGregor SN, Sholl JS, Hobart JM, Neerhof MG, Ragin A. Comparative trial of prednisone plus aspirin vs aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993: 169: 1411-1417.
63. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose aspirin therapy. Am J Obstet Gynecol 1992; 166: 1318-1323.
64. Balasch J, Carmona F, Lopez-Soto A et al. Low dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome. Hum Repord 1993; 8: 2234-2239.
65. Sanchez-Guerrero J, Alarcon-Segovia D, Course of antiphospholipid antibodies in patients with primary antiphospholipid syndrome before, during and after pregnancy treated with low dose aspirin, relationship of antibody levels to outcome in 7 patients. J Rheum 1992; 19: 1083-1086.
66. Buchanan NM, Khamashta MA, Morton KE, Kerslake S, Baguley EA, Hughes GRV. A study of 100 high risk lupus pregnancies. Am J Reprod Immunology 1992; 28: 192-194.
67. Rosove MH, Tabsh K, Wasserstrum N, Howard P, Hahn BH, Kalunian KC. Heparin treatment for women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol 1990; 75: 630-634.
68. de Swiet M, Ward PD, Fidler J et al. Prolonged heparin therapy in pregnancy causes bone demineralization. Br J Obstet Gynecol 1983; 90: 1129-1134.
69. Scott JR, Branch DW, Kochenour NK, Ward K. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization. Am J Obstet Gynecol 1988; 159: 1055-1056.
70. Francois A, Freund M, Daffos F, Remy P, Aiach M Jacquot C. Repeated fetal losses and the lupus anticoagulant. Ann Int Med 1988; 109: 993-994.
71. Wapner RJ, Cowchock FS, Shapiro SS. Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions. Am J Obstet Gynecol 1989; 161: 1271-1272.
72. Spinnato JA, Clark AL, Pierangeli SS, Harris EN. Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy. Am J Obstet Gynecol 1995; 172: 690-694.
73. Park A, Maier D, Wilson D, Andreoli J, Ballow M. Intravenous gamma-globulin, antiphospholipid antibodies and pregnancy. Ann Int Med 1989; 110: 495-496.
74. Kaaja R, Julkunen H, Ammala P, Palosuo T, Kurki P. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies. Acta Obstet Gynecol Scand 1993; 72: 63-66.
75. Arnout J, Spitz B, Wittevrongel C, Vanrusselt M, Assache AV, Vermylen J. High-dose intravenous immunoglobulin treatment of a pregnant patient with an antiphospholipid syndrome: immunological changes associated with a successful outcome. Thromb Hemostasis 1994; 71: 741-747.
76. Reece EA, Gabrielli S, Cullen MT, Zheng X-Z, Hobbins JC, Harris NE. Recurrent adverse pregnancy outcome and antiphospholipid antibodies. Am J Obstet Gynecol 1990; 163: 162-169.
77. Frampton G, Cameron JS, Thom M, Jones S, Raferty M. Successful removel of antiphospholipid antibody during pregnancy using plasma exchange and low-dose prednisone. Lancet 1987; 2: 1023-1024.
78. Fulcher D, Stewart G, Exner T, Trudinger B, Jeremy R. Plasma exchange and the anticardiolipin syndrome in pregnancy. [Letter]. Lancet 1989; 2: 171.
79. Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989; 160: 439-443.
80. Silveira LH, Hubble CL, Jara LJ et al. Prevention of anticardiolipin related pregnancy loss with prednisone and aspirin. Am J Med 1992; 93: 403-411.
81. Lubbe WF, Palmer SJ, Butler WS, Liggins GC. Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet 1983; 1: 1361-1363.
82. Ordi J, Barquinero J, Vilardell M et al. Fetal loss treatment in patients with antiphospholipid antibodies. Ann Rheum Dis 1989; 48: 798-802.
83. Many A, Pauzner R, Carp H, Langevitz P, Martinowitz U. Treatment of patients with antiphospholipid antibodies during pregnancy. Am J Reprod Immunology 1992; 28: 216-218.